English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 864689      Online Users : 281
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/10009


    Title: Beta1 integrin as a prognostic and predictive marker in triple-negative breast cancer
    Other Titles: β1 integrin as a prognostic and predictive marker in triple-negative breast cancer
    Authors: Yin, HL;Wu, CC;Lin, CH;Chai, CY;Hou, MF;Chang, SJ;Tsai, HP;Hung, WC;Pan, MR;Luo, CW
    Contributors: National Institute of Cancer Research
    Abstract: Triple negative breast cancer (TNBC) displays higher risk of recurrence and distant metastasis. Due to absence of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), TNBC lacks clinically established targeted therapies. Therefore, understanding of the mechanism underlying the aggressive behaviors of TNBC is required for the design of individualized strategies and the elongation of overall survival duration. Here, we supported a positive correlation between beta1 integrin and malignant behaviors such as cell migration, invasion, and drug resistance. We found that silencing of beta1 integrin inhibited cell migration, invasion, and increased the sensitivity to anti-cancer drug. In contrast, activation of beta1 integrin increased cell migration, invasion, and decreased the sensitivity to anti-cancer drug. Furthermore, we found that silencing of beta1 integrin abolished Focal adhesion kinese (FAK) mediated cell survival. Overexpression of FAK could restore cisplatin-induced apoptosis in beta1 integrin-depleted cells. Consistent to in vitro data, beta1 integrin expression was also positively correlated with FAK (p = 0.031) in clinical tissue. More importantly, beta1 integrin expression was significantly correlated with patient outcome. In summary, our study indicated that beta1 integrin could regulate TNBC cells migration, invasion, drug sensitivity, and be a potential prognostic biomarker in TNBC patient survival.
    Date: 2016-09
    Relation: International Journal of Molecular Sciences. 2016 Sep;17(9):Article number 1432.
    Link to: http://dx.doi.org/10.3390/ijms17091432
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1422-0067&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000385525500059
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85016089903
    Appears in Collections:[洪文俊] 期刊論文

    Files in This Item:

    File Description SizeFormat
    PUB27589736.pdf5955KbAdobe PDF425View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback